140 related articles for article (PubMed ID: 33099202)
1. Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
Santos LL; Wertaschnigg D; Rolnik DL; Da Silva Costa F; Syngelaki A; Dimitriadis E; Nicolaides KH
Placenta; 2021 Jan; 103():76-81. PubMed ID: 33099202
[TBL] [Abstract][Full Text] [Related]
2. Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia.
Wertaschnigg D; Rolnik DL; Nie G; Teoh SSY; Syngelaki A; da Silva Costa F; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Dec; 56(6):879-884. PubMed ID: 32388891
[TBL] [Abstract][Full Text] [Related]
3. Association between the maternal serum levels of 19 eicosanoids and pre-eclampsia.
Long A; Ma S; Li Q; Lin N; Zhan X; Lu S; Zhu Y; Jiang L; Tan L
Int J Gynaecol Obstet; 2016 Jun; 133(3):291-6. PubMed ID: 27039049
[TBL] [Abstract][Full Text] [Related]
4. Second and third trimester serum levels of HtrA1 in pregnancies affected by pre-eclampsia.
Skinner S; Rolnik DL; Wang Y; Nie G; Syngelaki A; Nicolaides KH; da Silva Costa F
Placenta; 2021 Mar; 106():1-6. PubMed ID: 33601219
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.
Wright D; Krajewska K; Bogdanova A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):755-61. PubMed ID: 26726123
[TBL] [Abstract][Full Text] [Related]
7. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
[TBL] [Abstract][Full Text] [Related]
8. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
[TBL] [Abstract][Full Text] [Related]
10. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma.
Oliveira Perucci L; Pereira Santos TA; Campi Santos P; Ribeiro Teixeira LC; Nessralla Alpoim P; Braga Gomes K; Pires Sousa L; Sant'Ana Dusse LM; Talvani A
Am J Reprod Immunol; 2020 Feb; 83(2):e13206. PubMed ID: 31679164
[TBL] [Abstract][Full Text] [Related]
11. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.
Wright A; Guerra L; Pellegrino M; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):762-7. PubMed ID: 26726121
[TBL] [Abstract][Full Text] [Related]
13. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
Fetal Diagn Ther; 2014; 35(4):249-57. PubMed ID: 24642536
[TBL] [Abstract][Full Text] [Related]
16. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
17. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
[TBL] [Abstract][Full Text] [Related]
19. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women.
Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H
Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346
[TBL] [Abstract][Full Text] [Related]
20. Maternal cardiac function at 19-23 weeks' gestation in prediction of pre-eclampsia.
Gibbone E; Wright A; Vallenas Campos R; Sanchez Sierra A; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2021 May; 57(5):739-747. PubMed ID: 33294998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
